Matt Miller

So yes, you look at the stock performance.

Again, that's only the public equity side of this story.

So even when you talk to, as I do, investors who operate in both the private and public space,

It's a bit more of a complex and, again, debated story from a public equity perspective, but we continue to see the company finding willing investors to help back its credit and willing consumers in the likes of Amedda to sign some of these contracts because there are trillions of dollars at risk.

Yeah.

CoreWeave shares up 98.5% in the past 12 months.

Nebius up 360%.

Bloomberg's Bailey Lipschultz covers the markets for us.

Coming up, autonomous boat startup Ceronic raises $1.75 billion as the wave of funding into defense tech continues.

More on that next.

This is Bloomberg Tech.

Eastern.

Make us part of your weekend routine on Bloomberg Television, radio, and wherever you get your podcasts.

For decades, people traveled across the world to see John of God, desperate for cures no doctor could offer.

And when they arrived, they saw things they couldn't explain.

But behind those adoring crowds was something much darker.

I'm your host, Martina Castro.

And in the podcast Two-Faced, John of God, we'll look back on a man who claimed he could perform miracles and got people from all around the world to believe him.

From Exactly Right and Adonde Media, this is Two-Faced, John of God.

Listen on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts.